Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Otero, Santiago"'
Autor:
Alana Aragón-Herrera, Sandra Moraña-Fernández, Manuel Otero-Santiago, Laura Anido-Varela, Manuel Campos-Toimil, Javier García-Seara, Ana Román, José Seijas, Lucía García-Caballero, Javier Rodríguez, Estefanía Tarazón, Esther Roselló-Lletí, Manuel Portolés, Ricardo Lage, Oreste Gualillo, José Ramón González-Juanatey, Sandra Feijóo-Bandín, Francisca Lago
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 161, Iss , Pp 114535- (2023)
The pharmacological inhibition of sodium-glucose cotransporter 2 (SGLT2) has emerged as a treatment for patients with type 2 diabetes mellitus (T2DM), cardiovascular disease and/or other metabolic disturbances, although some of the mechanisms implica
Externí odkaz:
https://doaj.org/article/25810c314aa64857b4150a43206f7eb0
We generalise Starobinsky's model of inflation to space-times with $D>4$ dimensions, where $D-4$ dimensions are compactified on a suitable manifold. The $D$-dimensional action features Einstein-Hilbert gravity, a higher-order curvature term, a cosmol
Externí odkaz:
http://arxiv.org/abs/1702.08311
Autor:
Juan M. Vázquez-Lago, Rodrigo A. Montes-Villalba, Olalla Vázquez-Cancela, María Otero-Santiago, Ana López-Durán, Adolfo Figueiras
Publikováno v:
Antibiotics, Vol 12, Iss 3, p 558 (2023)
Antibiotic resistance is a significant public health concern, with numerous studies linking antibiotic consumption to the development of resistance. As medical students will play a pivotal role in prescribing antibiotics, this research aimed to ident
Externí odkaz:
https://doaj.org/article/648b002336614bb79be9d039500f11a6
Autor:
Alana Aragón-Herrera, Manuel Otero-Santiago, Laura Anido-Varela, Sandra Moraña-Fernández, Manuel Campos-Toimil, Tomás García-Caballero, Luis Barral, Estefanía Tarazón, Esther Roselló-Lletí, Manuel Portolés, Oreste Gualillo, Isabel Moscoso, Ricardo Lage, José Ramón González-Juanatey, Sandra Feijóo-Bandín, Francisca Lago
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The EMPA-REG OUTCOME (Empagliflozin, Cardiovascular Outcome Event Trial in patients with Type 2 Diabetes Mellitus (T2DM)) trial evidenced the potential of sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of patients with diabetes a
Externí odkaz:
https://doaj.org/article/0582b3904297450b8681e7c0da82b354
Autor:
Benítez-Estévez, Alfonso J., Otero Santiago, Manuel Francisco, Oliver Sáez, Paloma, Lirón Hernández, Javier, Rodríguez Cantalejo, Fernando, Sánchez Mora, Catalina, Caballé Martín, Imma, Bedini Chesa, José Luis, García Raja, Ana M., León Justel, Antonio, Venta Obaya, Rafael, Quinteiro García, Ana Isabel, Torra Puig, Montserrat
Publikováno v:
In Revista del Laboratorio Clinico July-September 2019 12(3):e47-e56
Autor:
Sandra Feijóo-Bandín, Alana Aragón-Herrera, Manuel Otero-Santiago, Laura Anido-Varela, Sandra Moraña-Fernández, Estefanía Tarazón, Esther Roselló-Lletí, Manuel Portolés, Oreste Gualillo, José Ramón González-Juanatey, Francisca Lago
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 10, p 5634 (2022)
Sodium-glucose co-transporter 2 inhibitors, also known as gliflozins, were developed as a novel class of anti-diabetic agents that promote glycosuria through the prevention of glucose reabsorption in the proximal tubule by sodium-glucose co-transport
Externí odkaz:
https://doaj.org/article/c7e3bfbb9d714e2db1a5f52e4163d6b8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Oliver Sáez, Paloma, Alonso Díaz, Ricardo, Lirón Hernández, Javier, Monzó Inglés, Vicente, Navarro Segarra, Xavier, Noval Padillo, José Ángel, Otero Santiago, Manuel, Rodríguez Cantalejo, Fernando, Sánchez Mora, Catalina, Rodríguez Fraga, Olaia
Publikováno v:
In Revista del Laboratorio Clinico April-June 2016 9(2):60-80
Autor:
S Morana-Fernandez, A Aragon-Herrera, M Otero-Santiago, L Anido-Varela, E Tarazon, M Portoles, E Rosello-Lleti, F Comella, J R Gonzalez-Juanatey, S Feijoo-Bandin, F Lago
Publikováno v:
European Heart Journal. 43
EMPA-REG OUTCOME (Empagliflozin, Cardiovascular Outcome Event Trial) trial highlighted the relevance of pharmacological inhibition of sodium-glucose cotransporter 2 (SGLT2) for the treatment of patients with type 2 diabetes mellitus (T2DM) and/or car